• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace

by March 8, 2025
by March 8, 2025

Walgreens Boots Alliance will be taken private by Sycamore Partners in a $10 billion deal, the companies announced Thursday, marking the end of nearly a century of public trading for the US pharmacy giant.

The move comes after years of financial turbulence that saw Walgreens’ market value plummet from a peak of $100 billion to just $9.3 billion.

Sycamore will pay $11.45 per share, an 8% premium over Walgreens’ closing price of $10.60 on Thursday.

In addition, shareholders could receive up to $3 per share in cash from future monetization of Walgreens’ stake in primary-care provider VillageMD.

The total transaction, including debt and payouts, is valued at approximately $23.7 billion, according to investment bank Leerink Partners.

Amazon, Walmart, eat into Walgreens’ share

Walgreens has struggled to keep pace with changes in the retail pharmacy landscape, losing ground to competitors such as Amazon and Walmart.

While rivals diversified into insurance and prescription management, Walgreens pursued an aggressive expansion strategy, investing billions into acquiring other pharmacy chains, including European giant Alliance Boots.

However, the shift away from brick-and-mortar retail left the company exposed to declining foot traffic and shrinking drug margins.

The company’s market capitalization has fallen by 90% since 2015, and its debt burden has swelled to nearly $30 billion.

Walgreens reported a net loss of $8.6 billion for the 2024 fiscal year, nearly three times the previous year’s losses.

While the company recently surpassed earnings and revenue expectations in its most recent quarter, analysts say the turnaround remains a long-term challenge.

“You have a business that is shrinking, and then you layer on losses and cash burn, all of that was the perfect recipe for what we are seeing today,” said Brian Tanquilut, a healthcare services research analyst at Jefferies in a Reuters report.

Strategic missteps by leadership compounded woes

Walgreens has spent years exploring potential buyers for parts of its business.

In 2019, private equity firm KKR reportedly offered $70 billion to take the company private, but the talks did not advance.

Now, Sycamore’s acquisition comes at a fraction of that valuation.

The company has also suffered from strategic missteps under former CEO Stefano Pessina, its largest single shareholder.

During his tenure, Walgreens’ market capitalization shrank by nearly half, and its expansion strategy failed to yield long-term gains.

The costly $5.2 billion investment in VillageMD, once seen as a path to healthcare diversification, has now become a financial drain and a potential divestment target for Sycamore.

Meanwhile, Walgreens’ main competitor, CVS, has successfully diversified its business beyond retail, acquiring health insurer Aetna for nearly $70 billion in 2018.

Walgreens reportedly considered buying insurer Humana but ultimately abandoned the idea, a move analysts now see as a missed opportunity.

Sycamore’s turnaround strategy

Sycamore, a private equity firm known for acquiring struggling retail brands, has a history of extracting value through cost-cutting measures, store closures, and asset sales.

The firm has previously acquired brands such as Staples, Talbots, and Nine West, often restructuring their operations to improve profitability.

Analysts expect Sycamore to follow a similar playbook with Walgreens, possibly selling off non-core assets like Boots, its UK-based pharmacy chain, and reducing operational costs across its retail footprint.

“Going private makes sense on paper,” said Ann Hynes, an analyst with Mizuho Bank, adding that Walgreens’ operational challenges would likely be better handled without commitments to shareholders.

Deal structure and potential roadblocks

The transaction includes a 35-day “go-shop” period, allowing Walgreens to solicit alternative bids.

However, analysts believe a competing offer is unlikely given the complexity of the deal.

“Given the size and number of moving parts involved—a potential split of the US business, Boots, and Health—we don’t expect a competing bid to emerge,” said Michael Cherny, an analyst at Leerink Partners.

With Walgreens set to go private, the future of its sprawling global operations remains uncertain.

While Sycamore’s takeover provides an opportunity for restructuring, questions remain about whether the firm’s strategy will lead to long-term growth or simply a short-term financial overhaul.

Investors and industry watchers will be closely monitoring the next steps as one of America’s most storied pharmacy chains transitions to a new chapter under private ownership.

The post Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Broadcom shares surge 10% after Q1-print: buy, sell or hold?
next post
Deep dive: Why Costco’s Q2 pleased investors despite an earnings miss

Related Posts

Commerzbank sees China economic growth slowing in second...

June 27, 2025

JSW Paints to buy Akzo Nobel India for...

June 27, 2025

Europe markets open: stocks rise as US hints...

June 27, 2025

US-China sign trade deal, 10 more with trading...

June 27, 2025

Xiaomi stock price hits record high as Apple...

June 27, 2025

NTT Data Group plans Singapore REIT IPO in...

June 27, 2025

Jio Financial shares rally close to 5% after...

June 27, 2025

CAC 40 2025 outlook: Biggest winners and losers...

June 27, 2025

From best to worst: Why Trade Desk stock...

June 27, 2025

HBAR drops 1.63% as short bets rise and...

June 27, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Despite Tariffs, Inflation Remained Low in May

    June 28, 2025
  • Despite Tariffs, Inflation Remained Low in May

    June 27, 2025
  • PBS and NPR: A Free Press Doesn’t Need a Government Budget Line 

    June 27, 2025
  • Trump v Powell: The Credibility Cost of Politicized Monetary Policy

    June 27, 2025
  • Consumer IoT Products are Priced 44% Higher on Average Than Similar Non-Connected Products

    June 27, 2025
  • Morse Micro Wi-Fi HaLow Technology Receives Matter Certification

    June 27, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 5

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 6

    Elon Musk says federal employees must fill out productivity reports or resign

    February 23, 2025
  • 7

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025

Categories

  • Economy (1,643)
  • Editor's Pick (171)
  • Investing (185)
  • Stock (1,062)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

FTSE 100 and FTSE 250 shares to...

April 18, 2025

USDT issuer Tether eyes investment in Italian...

March 27, 2025

Musk, Trump dial back feud as White...

June 6, 2025